Pharmacology of ADHD - Martin Flashcards
short acting methylphenidate
ritalin
long acting methylphenidate
ritaline LA
concerta
daytrana - patch
dexmethylphenidate
d-threo enantiomer of methylphenidate
adderall
mixed salt amphetamine - short acting
adderall XR
mixed salt amphetamine - long acting
atomoxetine
strattera
non-stimulant
triad of ADHD
inattentive, hyperactive, impulsive
maladaptive
onset before 12
ADHD prevalence
8% school age children
majority adolescents
criteria diagnose ADHD
6 or more sx
- inattention
- hyperactivity/impulsivity
onset before 12yo
impair 2 settings
impair social, academic, occupation
majority of ADHD
combined type
need to specify - predom inattentive, predom hyperactive/impulse or combined
ADHD characters
biologic
not moral disorder
behavioral syndrome
involves biochem messengers - DA, NE, E, etc.
methylphenidate
stimulant
dextroamphetamine
stimulant
lisdexamfetaline
stimulant
oral prodrug - converted to d-amphetamine
longer duration
cannot be crushed and injected
stimulant MOA
increased DA
-block reuptake
work to increase DA and NE available
activate inhibitor neurons
amphetamines MOA
block DA reuptake
-displace DA and NE - displacing natural storage vesicles
atomoxetine MOA
NE reuptake inhibitor
unknown mechanism - increased prefrontal cortex DA
methylphenidate NT
increased DA
amphetamine NT
increased NE and DA
atomoxetine NT
increase NE
guanfacine, clonidine MOA
decrease CNS sympathetic outflow
goal of stimulant tx
improve concentration
adverse stimulants
tics
appetite suppression
anemia
sleep disturbance
block DA reuptake
methylphenidate
fruit juice
decreased absorption of amphetamines
sodium bicarb
increased absorption of amphetamines
diversion
selling or giving drugs to others
lisdexamfetamine - vyvanse - less abuse, diversion, OD
untreated ADHD
more substance abuse
tx - significantly decreases risk
pt who not respond or can’t tolerate stimulant
or refuse controlled substance tx
atomoxetine
strattera
clonidine
alpha2 agonist
decreased central sympathetic output
also in children - sleep problems
guanfacine
alpha2 agonist
central acting antiHTN
TCAs
not 1st line for ADHD - but efficacious
schedule II drugs
dexmethylphenidate
methylphenidate
dextroamphetamine
amphetamine mixed salts
high concentration amphetamine
block SERT
amphetamine
block DAT and NET
IR-MPH
immediate release methylphenidate
-short acting
within 30 min - peak 1-3 hours
DOA 3-5 hours
used combo with long duration
boost in morning
concerta
osmotic release
DOA 12 hours
methylphenidate
daytrana
patch
acid urine
more amphetamine excretion
DOA dextroamphetamine
starts - 1 hour ingestion
DOA 5 hours
2x daily dosing
black box atomoxetine
suicide